DYSPORT 300 U/VIAL x 1

Package Size: 1
Active Ingredient: BOTULINUM TOXIN TYPE A 300 U/VIAL
Form of Administration: Subcutaneous, intramuscular
Registered Importer: MEDISON PHARMA LTD
Manufacturer: IPSEN BIOPHARM LTD, UK
Label: Dysport is indicated for symptomatic treatment of focal spasticity of: – Upper limbs in adults due to stroke or traumatic brain injury – Lower limbs in adults affecting the ankle joint due to stroke or traumatic brain injury (TBI) – Dynamic equinus foot deformity in ambulant pediatric cerebral palsy patients, two years of age or older.- Upper limbs in pediatric cerebral palsy patients, two years of age or older. Dysport is indicated in adults for symptomatic treatment of:- Spasmodic torticollis- Blepharospasm- Hemifacial spasm. Dysport is indicated for symptomatic treatment of persistent severe primary hyperhidrosis of the axillae, which interferes with the activities of daily living and is resistant to topical treatment. Dysport is indicated for the temporary improvement in the appearance of moderate to severe:- glabellar lines (vertical lines between the eyebrows ) seen at frown, and/or – Lateral canthal lines (crow’s feet lines) seen at maximum smile in adult patients under 65 years, when the severity of these lines has an important psychological impact on the patient.
Shelf Life: 24 months